NON OPIOD ANALGESICS

/ Uncategorized / By
  1. New lead for pain treatment: the synthesis of conolidine, a scarce, naturally occurring compound, has enabled the first studies of its pharmacological properties to be …
  2. Natural Product Kills Pain, But How?
  3. Use of non-opioid Analgesics as first line treatment for acute pain management by emergency medical services providers
  4. SYNFORM ISSUE 2011/9
  5. Phytochemical composition and antinociceptive activity of Bauhinia glauca subsp. hupehana in rats
  6. The Impact of Mental Health and Opioid Analgesic Use on Healthcare Utilization and Expenditures Among Back Pain Patients
  7. Total Synthesis of Heliolactone and its Biological Evaluation in Plants
  8. Red-hot chili peppers: a spicy new approach to preventing postoperative pain
  9. Aquaporin-4 facilitator TGN-073 demonstrates novel analgesic activity
  10. Laparoscopic presacral neurolysis for endometriosis‐related pelvic pain
  11. Anthelmintic and Analgesic Activities of Trachyspermum Khasianum H. Wolff
  12. Stepped Analgesic Approach to Chronic Malignant Pain
  13. Analgesic effects of cannabinoids for chronic non-cancer pain: A systematic review and meta-analysis with meta-regression
  14. Analgesic Poisoning
  15. Discovery of conolidine derivative DS39201083 as a potent novel analgesic without mu opioid agonist activity
  16. Medicinal plants for joint pain in traditional Persian medicine
  17. Non-opioid analgesic use and concerns for impaired organ protection
  18. Anti-inflammatory and analgesic activity of ethanolic extract of Kaempferia rotunda rhizome in rats
  19. Enantioselective approach to 7-azabicyclo [2.2. 1] heptane ring systems using D-(−)-quinic acid as the chiral educt: application to the formal synthesis of (+) …
  20. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats
  21. Antinociceptive effect of systemically administered dipyrone (metamizol), magnesium chloride or both in a murine model of cancer
  22. Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis and possible involvement of the adenosine system
  23. Knowledge of cannabinoids among patients, physicians, and pharmacists
  24. Antinociceptive activities of Artocarpus lacucha Buch-ham (Moraceae) and its isolated phenolic compound, catechin, in mice
  25. Synergistic interaction between acetaminophen and carbamazepine in mice.
  26. Pain management in opioid maintenance treatment
  27. SCALE UP OF SOLID ORAL DOSAGE FORM WITH COMBINATION OF THREE DIFFERENT DRUGS
  28. RP-HPLC method for simultaneous estimation of paracetamol and ibuprofen in tablets
  29. Discovery of a novel bicyclic compound, DS54360155, as an orally potent analgesic without mu-opioid receptor agonist activity
  30. A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater
  31. Aqueous and methanol extracts of Paullinia pinnata L.(Sapindaceae) improve inflammation, pain and histological features in CFA-induced mono-arthritis: Evidence …
  32. Evaluation of the Antioxidant and Analgesic Activities of Hydromethanolic Extract of Chromolaena odorata Leaf
  33. The toxicology investigators consortium case registry—the 2014 experience
  34. Phytochemical and Antinociceptive studies on the leaf extract of Ochna schweinfurthiana (Ochnaceae)
  35. Novel Molecular Targets for the Treatment of Pain
  36. Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises
  37. Anti-Inflammatory activity of Calotropis gigantea and Tridax procumbens on carrageenin-induced paw edema in rats
  38. Analgesic and antipyretic effects of Ecballium elaterium (L.) A. Richard. Extract in rodents
  39. New lead for pain treatment
  40. Synergistic analgesic activity of chloroform extract of Lawsonia inermis Linn. and Chlorophytum borivilianum Sant.
  41. Discovery and functional analysis of monoterpenoid indole alkaloid pathways in plants
  42. Prescription opioid use in pregnancy
  43. Analgesic use in contemporary burn practice: Applications to burn mass casualty incident planning
  44. Low-dose drug combinations along molecular pathways could maximize therapeutic effectiveness while minimizing collateral adverse effects
  45. Antioxidant, anti-inflammatory and antinociceptive activities of methanolic extract of Justicia secunda Vahl leaf
  46. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas
  47. Endorphin systems, pain and addiction
  48. Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis
  49. Experimental Evaluation of Analgesic and Antioxidant Effects of Hydromethanolic Extract of Dioscorea dumetorum Tuber
  50. Total synthesis of conolidine and apparicine
  51. Fate of pharmaceuticals in a subsurface flow constructed wetland and two ponds
  52. Evaluation of analgesic efficacy and ex vivo inhibition of cyclooxygenases 1 and 2 after use of metamizole (dipyrone) or meloxicam in cats undergoing elective …
  53. Neuronal nicotinic acetylcholine receptors as novel drug targets
  54. The Analgesic Effect of Pineapple Fruit Juice on Mice
  55. Bioactive alkaloids from medicinal plants of Bhutan
  56. Antiinflammatory Medicinal Plants from the Ugandan Greater Mpigi Region Act as Potent Inhibitors in the COX-2/PGH2 Pathway
  57. Possible Antinociceptive Mechanism and Site of Activity of Haruan (Channa Striatus) Crude Aqueous Extract in Mice
  58. Forensic Identifications of Papaver Somniferum (Opium) for Fatal Poisoning
  59. Phytochemical screening and quantification of phytoconstituents in Gmelina arborea fruits extracts
  60. The toxicology investigators consortium case registry—the 2012 experience
  61. The combination of mitragynine and morphine prevents the development of morphine tolerance in mice
  62. Occurrence of contaminants of emerging concern in aquatic ecosystems utilized by Minnesota tribal communities
  63. The endocannabinoid system as a potential therapeutic target for pain modulation
  64. Pain in respiratory disease
  65. The analgesic activity of bestatin as a potent APN inhibitor
  66. Computational studies of biologically active alkaloids of plant origin: an overview
  67. Prequels to synthetic biology: From candidate gene identification and validation to enzyme subcellular localization in plant and yeast cells
  68. Recent advances in the pharmacological management of pain
  69. Increasing the benefits and reducing the harms of prescription opioid Analgesics
  70. Recent developments in the field of arrow and dart poisons
  71. Comparison of Opioid-Free Anesthesia Versus Opioid-Containing Anesthesia for Elective Laparoscopic Surgery (COFA: LAP): A Protocol Measuring Recovery …
  72. Investigating the analgesic properties of Kurkinorin, a novel mu-opioid receptor analogue of Salvinorin A
  73. Cu-catalyzed synthetic process for acetaminophen from dihalobenzenes
  74. The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report
  75. A bioguided preclinical evaluation of Antinociceptive effects of Mondia Whytei plant extracts
  76. American Society of Regional Anesthesia and Pain Medicine’s 37th Annual Spring Meeting Report
  77. Anxiolytic-like and antinociceptive effects of 2 (S)-neoponcirin in mice
  78. Enhanced Antinociceptive Effects of Mitragynine in Combination with Morphine Via Opioid Receptors Activation
  79. Moxonidine, a Mixed a2‐Adrenergic and Imidazoline Receptor Agonist, Identifies a Novel Adrenergic Target for Spinal Analgesia
  80. A prospective, randomized, open-label study comparing an opioid-sparing postsurgical pain management protocol with and without liposomal bupivacaine for full …
  81. Therapeutic applications of natural products in herbal medicines, biodiscovery programs, and biomedicine
  82. Evaluation of the antinociceptive, anti-inflammatory and antipyretic activities of Ruta Graveolens L. in mice and rats
  83. Cannabinoids and pain: sites and mechanisms of action
  84. Dampening drug actions
  85. The toxicology investigators consortium case registry—the 2017 annual report
  86. Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls
  87. The toxicology investigators consortium case registry—the 2011 experience
  88. Characterization of the antinociceptive mechanisms of khat extract (Catha edulis) in mice
  89. Children toxic exposure in 2004–telephone poison information service
  90. Raw herb powders and powdered herb extracts in the treatment of chronic idiopathic pain: a methodology and case study
  91. Chiral 1, 1-diaryl compounds as important pharmacophores
  92. Targeting the pains of food insecurity and malnutrition among internally displaced persons with nutrient synergy and Analgesics in organ meat
  93. 22 Toxins Leading to Medicines
  94. Opium abuse and its problems in anesthesia practice: a review from bench to bedside
  95. Clinical application of glucocorticoids, antineuropathics, and other analgesic adjuvants for acute pain management
  96. Transmitters involved in antinociception in the spinal cord
  97. The Toxicology Investigators Consortium Case Registry—the 2019 Annual Report
  98. Magnesium sulfate and sufentanil for patient-controlled analgesia in orthopedic surgery
  99. Positional Cloning of Genes Contributing to Variability in Nociceptive and Analgesic Phenotypes
  100. Peripheral morphine analgesia resistant to tolerance in chronic morphine-treated mice
  101. Psychiatric effects of drugs for other disorders
  102. Non-narcotic anesthetic options for the patient in recovery from substance abuse
  103. Antinociceptive activity of Annona diversifolia Saff. leaf extracts and palmitone as a bioactive compound
  104. Gout remedies in traditional Iranian medicine (TIM)
  105. Blue Nile Flower Rituals from the Perspective of Transpersonal Psychology-The Role of Nuciferine and its Putative Value as an Antipsychotic Drug
  106. The Promise and Limitations of Broad-Spectrum Analgesics: Nicotinic Acetylcholine Receptor Agonists as a Potential Candidate
  107. EFFECT OF CERTAIN Analgesics ON SOME BIOCHEMICAL TRAITS OF ARABI EWES
  108. Investigating on the antioxidant effects of soybean extract on histopathological changes of liver in Gelofen treated mice
  109. The future of topical Analgesics
  110. A history of intraspinal analgesia, a small and personal journey
  111. 4 Contamination of Water with Drugs and Metabolites
  112. Vulvodynia and proctodynia treated with topical baclofen 5% and palmitoylethanolamide
  113. Edelweiss: Psychiatry Open Access (ISSN 2638-8073)
  114. The role of Mrgprs in pain
  115. Research progress on new preparations of lappaconitine.
  116. Orofacial antinociceptive effect of Mimosa tenuiflora (Willd.) Poiret
  117. Topical treatments for localized neuropathic pain
  118. Independent survey suggests pharmacists’ concerned about codeine-based Analgesics
  119. Antinociceptive activity of coniine in mice
  120. 2016 MARYLAND
  121. SOUTH CAROLINA
  122. Saving the oceans? They could save us!
  123. Evidence of mechanism of action of anti‐inflammatory/antinociceptive activities of acacetin
  124. Methadone for neuropathic pain in adults
  125. Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice
  126. Gmelina arborea–An indigenous timber species of India with high medicinal value: A review on its pharmacology, pharmacognosy and phytochemistry
  127. Synthesis, Characterization and Cytotoxicity Evaluation of New Heterocyclic Compounds with Oxazole Ring Containing 4-(Phenylsulfonyl) phenyl Moiety
  128. Solution of the multistep pathway for assembly of corynanthean, strychnos, iboga, and aspidosperma monoterpenoid indole alkaloids from 19E-geissoschizine
  129. –TAXONOMICAL CLUSTERING OF N-METHYLATED MONOTERPENOID INDOLE ALKALOIDS IN APOCYNACEAE
  130. Investigation of the effect of dipyrone on cells isolated from intervertebral disc tissue
  131. NSAIDs, COXIBs, CLOXIBs and cancer pain
  132. Clinically important meperidine toxicities
  133. Managing difficult pain conditions in the cancer patient
  134. Drug and addictive substance poisoning with medical pharmacologist assessment
  135. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system
  136. Photonic efficiency of the photodegradation of paracetamol in water by the photo-Fenton process
  137. Trifluoroacetic Acid (TFA)
  138. Update and review on the basics of pain management
  139. PERI-OPERATIVE PAIN MANAGEMENT FOR PAEDIATRIC ADENOTONSILLECTOMY
  140. Ethnopharmacological table on some reputedly psychoactive fumigatories among Middle and South American natives
  141. Endocannabinoid and N-acylethanolamide levels in rat brain and spinal cord following systemic dipyrone and paracetamol administration
  142. l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats
  143. OVERDOSEOF TUSSIRUM INDUCED HISTOPATHOLOGICAL CHANGES OF THE LIVER AND KIDNEY IN MALE DOMASTIC RABBITS
  144. Total synthesis of the Daphniphyllum alkaloid daphenylline
  145. The analgesic effect of rescue administration of intravenous acetaminophen in cancer patients may be associated with sex and opioid dose, and the effect would …
  146. Phencyclidine‐type catalepsy in the pigeon: An update on chen’s work
  147. Implementation of Nagoya Protocol and its Ethical Dilemma–the Case Study of Indonesia
  148. Activity-Directed Fractionation of Pleurotus ostreatus. in the Search for Analgesics
  149. Synthesis of optically active 1, 2, 3-trisubstituted azetidines employing an organocatalytic approach with L-proline
  150. Central antinociceptive and mechanism of action of Pereskia bleo Kunth leaves crude extract, fractions, and isolated compounds
  151. Pain management in hemophilia: expert recommendations
  152. Saving the oceans? They could save us!
  153. Best practices for monitoring opioid compliance—making the case for usingblood and liquid chromatography–tandem mass spectrometry for screen analysis.
  154. “Redundancy” of endocannabinoid inactivation: new challenges and opportunities for pain control
  155. Antinociceptive Synergy Between Metamizole and Hesperidin in a Model of Visceral Pain in Mice
  156. Spillover effects of the opioid epidemic on consumer finance
  157. Nicotinic acetylcholine receptor agonists: a potential new class of Analgesics
  158. Structurally diverse indole alkaloids from Ochrosia elliptica
  159. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients
  160. Pain management via local anesthetics and responsive hydrogels
  161. Poison frogs
  162. Mitigating the opioid epidemic in dental practice by promoting provider education and patient counseling
  163. 4.3. 4-TLMTs ARE ONLY PRESENT IN THE TRANSCRIPTOMES OF THE
  164. Dioclea violacea lectin ameliorates inflammation in the temporomandibular joint of rats by suppressing intercellular adhesion molecule-1 expression
  165. Effect of Acetaminophen (APAP) on Physiological Indicators in Lactuca sativa
  166. Interaction of a cannabinoid-2 agonist with Tramadol on nociceptive thresholds and immune responses in a rat model of incisional pain
  167. Historical and current perspectives of neuroactive compounds derived from Latin America
  168. Natural Toxins as Leads in Drug Discovery
  169. Immunomodulatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) at the clinically available doses
  170. Product names, proper claims? More ethical issues in the marketing of drugs
  171. Essential Drugs
  172. 108 edetate calcium disodium
  173. Postoperative Analgesia: Randomized Prospective Study Comparing Epidural Catheter Infusion and Continuous Wound Catheter Infusion of Local Anaesthesia
  174. Molecular basis and clinical implications of opioid tolerance and opioid-induced hyperalgesia
  175. Postoperative pain after spinal surgery in the paediatric population
  176. Melocochines A and B, Two Alkaloids from the Fruits of Melodinus cochinchinensis
  177. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel Analgesics and anti-inflammatory agents
  178. Phoneutria spider toxins target channels involved in cardiac arrhythmias, ischemia and pain
  179. Molecular mechanism underlying orofacial antinociceptive activity of Vanillosmopsis arborea Baker (Asteraceae) essential oil complexed with β-cyclodextrin
  180. Synthesis, structure–activity relationship and antinociceptive activities of some 2-(2′-pyridyl) benzimidazole derivatives
  181. Opioid Alternatives for Athletes
  182. An Historical Analysis of the Perception of Pain & Pain Management Methods from 1800-1945
  183. Management of opioid use disorder in the emergency department: a white paper prepared for the American Academy of Emergency Medicine
  184. Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo [4.2. 1] non-2-ene UB-165
  185. Dielectric spectroscopic studies in supercooled liquid and glassy states of Acemetacin, Brucine and Colchicine
  186. Synthesis of methylcellulose/cellulose nano-crystals nanocomposites: Material properties and study of sustained release of ketorolac tromethamine
  187. Therapeutic potential of venom peptides
  188. Hemopressin as a breakthrough for the cannabinoid field
  189. The Pharmacogenetics of Opioid Treatment for Post-Operative Pain Management
  190. A Budding New Treatment? Cannabinoid Agonists for Cannabis Use Disorder
  191. Discovering the pharmacodynamics of conolidine and cannabidiol using a cultured neuronal network based workflow
  192. Jute cellulose nano-fibrils/hydroxypropylmethylcellulose nanocomposite: a novel material with potential for application in packaging and transdermal drug delivery …
  193. Managing physical symptoms
  194. Allosteric modulation of nicotinic acetylcholine receptors: the concept and therapeutic trends
  195. Construction of the hasubanan alkaloid core through an oxidative dearomatization/lewis acid catalyzed cyclization
  196. Pain pharmacology and the pharmacological management of pain
  197. Lessons from natural molecules
  198. Assessment of Groundwater Contamination Risk from Nonchemical Stressors in Wastewater
  199. Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools
  200. Frog tales–on poison dart frogs, epibatidine, and the sharing of biodiversity
  201. Convergent approach to the tetracyclic core of the apparicine class of indole alkaloids via a key intermolecular nitrosoalkene conjugate addition
  202. Does cryoneurolysis result in persistent motor deficits? A controlled study using a rat peroneal nerve injury model
  203. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature
  204. Therapeutic and cosmetic applications of mangiferin: an updated patent review (patents published after 2013)
  205. An audit of analgesic use for hand injuries in a private emergency department in Johannesburg
  206. The role of microglia in morphine tolerance
  207. Therapy and prevention of parasitic insects in veterinary medicine using imidacloprid
  208. Immersive virtual reality as analgesia during dressing changes of hospitalized children and adolescents with burns: a systematic review with meta-analysis
  209. Potassium channels in peripheral pain pathways: expression, function and therapeutic potential
  210. Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control
  211. Potential compounds for the treatment of mitochondrial disease.
  212. ANTINOCICEPTIVE EFFECTS AND MECHANISMS OF ACTION OF Clinacanthus nutans LINDAU LEAF METHANOLIC AND PETROLEUM ETHER EXTRACTS …
  213. Role of transient receptor potential ankyrin 1 (TRPA1) on nociception caused by a murine model of breast carcinoma
  214. Opioids in medicine: a comprehensive review on the mode of action and the use of Analgesics in different clinical pain states
  215. Mechanistic insights into the bioactivation of phenacetin to reactive metabolites: A DFT study
  216. The Management of a Patient with an Acute Stone Problem
  217. Managing Difficult Pain Conditions in the Cancer Patient
  218. Preparation and exploitation of versatile cyclohexanoid chiral building blocks
  219. The potential of alkaloids in drug discovery
  220. Heterogeneous catalytic ozonation of phenacetin in water using magnetic spinel ferrite as catalyst: Comparison of surface property and efficiency
  221. Unintentional poisoning deaths in Oklahoma, 2007–2011
  222. Drug Formulary
  223. Hospitalists’ Attitudes Toward Pain and the Use of Opioid Analgesics
  224. MANAGEMENT OF PAIN AND OTHER SYMPTOMS
  225. Discovering the pharmacodynamics of conolidine and cannabidiol using a cultured neuronal network based workflow
  226. Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons
  227. A randomized, double-blinded, placebo-controlled study of the effect of a combination of lemon verbena extract and fish oil omega-3 fatty acid on joint management
  228. List of drugs in development for neurodegenerative diseases: update June 2010
  229. Cannabidiol (CBD) Effects on State Opioid Death Rates (2010–2015)
  230. Potassium Channels
  231. Traditional Chinese medicine in the treatment of diabetes
  232. in a teaching hospital in Hong Kong
  233. What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims
  234. PENTAZOCINE VERSUS COMBINED PENTAZOCINE AND DICLOFENAC FOR PAIN RELIEF IN THE FIRST 24 HOURS AFTER CAESAREAN SECTION: A …
  235. Unravelling the binding mechanism and protein stability of human serum albumin while interacting with nefopam analogues: a biophysical and insilico approach
  236. Fate and Transport of Ibuprofen in the Natural Surface Water of the Pasig River, Philippines
  237. 12CREDITS
  238. Thin-layer chromatography methods for the determination of non-steroidal anti-inflammatory drugs and cephalosporin antibiotics: a review
  239. Chemical nature of synaptic transmission in vertebrates
  240. Synthetic Drugs: A” Viral” Outbreak.
  241. Affective disorders and neuropathic pain as mutually influential factors: contribution of the opioid system
  242. Inhibition of Mild Steel Corrosion by Gmelina arborea Root Extract in 1 M H2SO4 Solution
  243. Antiepileptic drugs as Analgesics/adjuvants in inflammatory pain: current preclinical evidence
  244. An overview on transient receptor potential channels superfamily
  245. Developing a dissociative nanocontainer for peptide drug delivery
  246. Studies Toward the Total Synthesis of Subincanadine E
  247. Kyotorphin derived peptides in the relationship between analgesia and alzheimer’s disease
  248. Stress and addiction: when a robust stress response indicates resiliency
  249. Novel Approach for the Search for Chemical Scaffolds with Activity at Both Acetylcholinesterase and the α7 Nicotinic Acetylcholine Receptor: A Perspective on …
  250. Think Before You Flush! A Sustainable Aquatic Eco-System’s Relation to Human Health
  251. 4 Planning for pain relief
  252. The management of chronic pain in Switzerland: a comparative survey of Swiss medical specialists treating chronic pain
  253. Ethanol extracts of Cassia grandis and Tabernaemontana cymosa inhibit the in vitro replication of dengue virus serotype 2
  254. Investigating Risk Factors for Pediatric Opioid Morbidity and Mortality
  255. Think before you flush! A sustainable aquatic eco-system’s relation to human health.
  256. Unintentional Poisoning Deaths in Oklahoma, 2007-2012
  257. Study of in Vitro Cytotoxicity and in Vivo Anti-Tumour and Anti-Inflammatory Activities of Gmelina Arborea Roxb. Stem Bark
  258. New vasorelaxant indole alkaloids, taberniacins A and B, from Tabernaemontana divaricata
  259. Management and treatment of Dengue and Chikungunya-natural products to the rescue
  260. The relationship between non-fatal overdose of pharmaceutical medications, suicidality and depression
  261. A chemical prioritization process: Applications to contaminants of emerging concern in freshwater ecosystems (Phase I)
  262. Effect of parsley oil on the kidney of albino rats offspring treated by Arcoxia drug (Etoricoxib) during the 2nd week of gestation
  263. Neuronal nicotinic receptors
  264. Wikidata: A large-scale collaborative ontological medical database
  265. CHARACTERIZATION AND ANTIMICROBIAL ACTIVITIES OF IBUPROFEN LYSINATE
  266. VIBRATIONAL MOVEMENT OF PARTICLE AT ASYMMETRICAL OSCILLATION OF THE WORKING SURFACE
  267. British Ubrary Ccta! ogulng in Publication Data A catalogue record for this book is available from the British Library
  268. General anesthesia mediated by effects on ion channels
  269. Amaryllidaceae Alkaloids as Anti-inflammatory Agents Targeting Cholinergic Anti-inflammatory Pathway: Mechanisms and Prospects
  270. Comparative metabolomics of aging in a long-lived bat: insights into the physiology of extreme longevity
  271. Perspectives in efficacy, safety and clinical evaluation of bioactive natural products
  272. An Evidence-based Perspective of Herbal Remedies for Cancer Patients
  273. GABAA receptor subtypes underlying general anesthesia
  274. Drug Discovery Targeted to Transthyretin Related Amyloidosis
  275. Therapeutic Reviews
  276. Characterization of Novel Cannabinoid Receptor 2-Selective Agonists at the Biochemical and Cellular Levels: Leads for Therapeutic Agents
  277. Error, Misuse, and Abuse of Prescription and Over-the-Counter Medications for Young Children.
  278. The business of pain medicine: the present mirrors antiquity
  279. A review on animal-based homoeopathic drugs and their applications in biomedicine
  280. Neurotransmitter receptors as potential targets of glaucoma pathogens
  281. Drug Treatment for Chronic Pain
  282. Error, Misuse, and Abuse of Prescription and Over-the-Counter Medications for Young Children Steven R. Shaw, Khing Su Lin, Tiffany W. Chiu, Melissa Stern …
  283. Archive for the category: Impact
  284. Soma, food of the immortals according to the Bower Manuscript (Kashmir, 6th century AD)
  285. Cannabinoid therapeutic potential in motivational processes, psychological disorders and central nervous system disorders
  286. Scar management in burn injuries using drug delivery and molecular signaling: current treatments and future directions
  287. Synthesis and stereochemical determination of an antiparasitic pseudo-aminal type monoterpene indole alkaloid
  288. Atypical’antidepressants in overdose
  289. Management of pain in renal failure
  290. Pediatric anesthesia: basic principles, state of the art, future
  291. Aspidosperma species: A review of their chemistry and biological activities
  292. Recent developments in the synthesis of nicotinic acetylcholine receptor ligands
  293. EXERCISE AND CANCER
  294. Current pharmacotherapeutic strategies in rheumatic diseases and other pain states
  295. PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches
  296. Managing migraine with over-the-counter provision of triptans: the perspectives and readiness of Western Australian community pharmacists
  297. GABA, The Major Inhibitory Neurotransmitter in the Brain
  298. Oregon: Pain, Healthcare’s Persistent Challenge, 6 units
  299. In Vitro and in vivo neuroprotective effects of stellettin B through anti-apoptosis and the Nrf2/HO-1 pathway
  300. Cone snail venomics: From novel biology to novel therapeutics
  301. Advances in D-Amino Acids in Neurological Research
  302. An antipsychotic drug: Spectroscopic identification, structural features, DFT computations and molecular docking studies on 4-(methylamino)-3-nitrobenzoic acid
  303. Cholinergics/Anticholinergics/Muscarinics/Nicotinics
  304. Degradable polymeric vehicles for postoperative pain management
  305. Biocatalysis in the Swiss manufacturing environment
  306. A Comparative Study of Efficacy, Side Effects and their Management of Naproxen and Flupirtine in Cancer Patients.
  307. The role of the brain’s endocannabinoid system in pain and its modulation by stress
  308. Fimbristylis ovata extract and its ability to encounter AGEs-induced neurotoxicity in SH-SY5Y
  309. Data-driven soft-sensors for online monitoring of batch processes with different initial conditions
  310. Peptides, peptidomimetics, and polypeptides from marine sources: A wealth of natural sources for pharmaceutical applications
  311. Palladium Chemistry in Pyridine Alkaloid Synthesis
  312. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders
  313. Novel and potent 6-chloro-3-pyridinyl ligands for the α4β2 neuronal nicotinic acetylcholine receptor
  314. ENERGY AND FUEL–TRADITIONAL AND ALTERNATIVE SOURCES
  315. Zoo animal and wildlife immobilization and anesthesia
  316. 7 Palliative Care
  317. Industrial applications of the Diels–Alder reaction
  318. Update of the Scientific Opinion on opium alkaloids in poppy seeds
  319. Tool Kit
  320. Palliative Care
  321. Stimulant, narcotic, and hallucinogen use among long distance commercial drivers in Sokoto: A survey on prevalence and consequential knowledge
  322. Physiological and pathological role of TRPV1, TRPV2 and TRPV4 channels in heart
  323. warrant the postponement of surgery in such patients? There is much variation in practise and confusion in this area [1]. This editorial hasn’t helped.
  324. Symptom management
  325. Synthesis of optically active 1, 2, 3-trisubstituted azetidines employing an organocatalytic approach with L-proline
  326. Pyrolytic Fate of Synthetic Cannabinoids
  327. Spinal DN-9, a peptidic multifunctional opioid/neuropeptide FF agonist produced potent nontolerance forming analgesia with limited side effects
  328. Arterial Ulcer-Treatment
  329. Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs
  330. Drug Class Review on Long-Acting Opioid Analgesics
  331. Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy
  332. SYNTHETIC STUDIES TOWARDS THE NATURAL PRODUCT LEOPOLIC ACID A
  333. Nutritional and Dietary Supplements: Code or Concern
  334. Doing things with frogs
  335. Analgesic and antineuropathic drugs acting through central cholinergic mechanisms
  336. Neuronal nicotinic acetylcholine receptor ligands as potential Analgesics
  337. Black’s medical dictionary
  338. Evaluation of the antinociceptive properties of Hyptis crenata Pohl (Brazilian mint)
  339. 3 Perioperative Nonopioid Analgesics of Use in Pain Management for Spine Surgery
  340. The fall and rise of pharmacology–(Re-) defining the discipline?
  341. Unraveling the metabolism and transmembrane transport of the highly valuable medicinal alkaloids from Catharanthus roseus
  342. Novel ligands for the neuronal nAChR: Synthesis, in vitro characterizations and binding models
  343. The rational use of intrathecal opioid Analgesics
  344. From the Bottom Up: Chemotherapy-Induced Gut Toxicity, Glial Reactivity and Cognitive Impairment
  345. Drug use, impaired driving and traffic accidents
  346. Development of an iron oxide nanoparticle-activated carbon adsorbent for water treatment of common human pharmaceutical chemicals
  347. Alternative Binding Scaffolds: Multipurpose Binders for Applications in Basic Research and Therapy
  348. ISOLATION AND CHARACTERIZATION OF THE CYTOTOXIC COMPONENTS OF A FIJIAN SPONGE, HIPPOSPONGIA SP.
  349. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure–Activity Relationship Studies
  350. Role of the α5 nAChR subunit during pain processing mechanisms in spinal and supraspinal regions
  351. Chronic Cannabis Use and Attention-modulated Prepulse Inhibition of the Startle Reflex in Humans
  352. Problem Drug Use
  353. GABA
  354. A generic parallel combinatorial strategy to water tolerant asymmetric catalysis.
  355. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes
  356. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes
  357. Pain: Healthcare’s Persistent Challenge
  358. Therapeutic use of botulinum toxin in pain treatment
  359. In Search for FXR Gene Selective Modulators: Synthesis, Biological Activity and Docking Studies of 23-N-Carbocinnamyloxy-Norchenodeoxycholanyl-amine (UPF838 …
  360. Therapeutic Strategies
  361. Discogenic back pain: the induction and prevention of a pro-inflammatory cascade in intervertebral disc cells in vitro
  362. Gene therapy for the treatment of chronic peripheral nervous system pain
  363. The role of neuronal KV7 channels in the antinociceptive action of paracetamol
  364. Prion diseases
  365. Progress towards the synthesis of Indolizidine alkaloid 223AB
  366. Pharmacogenetics of CYP2D6 and CYP2C19 as a pre-prescription tool for drug efficacy and toxicity in a demographically-representative sample of theSouth African …
  367. Clinical and Histological Outcomes of Allogenic Amnion-Chorion Membrane in the Healing of Free Gingival Graft Donor Site
  368. Biocatalysis at Room Temperature
  369. K+ Channels in Primary Afferents and Their Role in Nerve Injury-Induced Pain
  370. Biotransformations of drugs belonging to nitrogen heterocycles
  371. Pharmacology for students of bachelor’s programmes at MF MU (special part)
  372. Molecular Signatures of Chronic Pain Subtypes
  373. Prediction of drug-like properties
  374. The Ying and Yang of Pain: Protective Versus Damaging
  375. Where spiders and cone snails meet: development of novel sodium channel probes
  376. Design of biologically active macromolecules based on ferrocene and arene complexes
  377. Isolation of New Secondary Metabolites from New Zealand Marine Invertebrates
  378. Dr. Barbara Sherman
  379. Drug metabolism and pharmacokinetics in the lead optimisation of novel positive allosteric modulators of α1 strychnine sensitive glycine receptors
  380. Poster Communications Session 1: Antimicrobials & Antibiotic resistance
  381. Opportunities in pain therapy: beyond the opioids and NSAIDs
  382. Microbial Degradation of Pyridine and Pyridine Derivatives
  383. 2008 CONFERENCE CO-SPONSORS
  384. A Critical Analysis of Travel Advice given to Employees Travelling Abroad
  385. The SPARC-null Mouse Model of Low Back Pain: Mechanism, Treatment, and Translation to Humans
  386. Oral treatment options for degenerative joint disease—presence and future
  387. REVIEW ON DIABETIC WOUND HEALING THERAPY
  388. Imaging nociceptive signaling in peripheral CGRP terminal fibres
  389. Download (4Mb)-Etheses-Saurashtra University
  390. Central nervous system effects and neurotoxicity
  391. Genoprotective effect of aspirin and ibuprofen in human lymphocyte cells. Effect of nano and bulk forms of aspirin and ibuprofen on lymphocytes from breast cancer …
  392. The pharmacotherapy of chronic pain: a review
  393. Evaluation of three J-ARC pilot projects.
  394. 12 Anesthesiological procedures
  395. Extraction and nanoparticle preparation of natural materials by using supercritical carbon dioxide
  396. Synthesis of Natural Abundant Butenolides and Analogues
  397. Chronic Pain Medication & Treatment Guide
  398. AAPM 2017 Annual Meeting Abstracts
  399. Development of flow methodologies for the [2+ 2] photocycloaddition of cinnamic acid derivatives and biological exploration of truxinic acid derived scaffolds
  400. The effects of nicotine on antinociception in male and female Sprague-Dawley and Long-Evans rats with and without stress
  401. Drugs influencing the metabolism
  402. Natural Products Studies of Marine Organisms of the South Pacific
  403. The synthesis of 5-substituted E ring, and B/E ring analogues of methyllycaconitine (MLA)
  404. AUTOSOMAL TRISOMY: A CYTOGENETIC STUDY IN LUCKNOW REGION
  405. Application of chromatography and coupled chromatography-mass spectrometry for the investigation of pharmacokinetics and metabolism of propofol, clofelin …
  406. Letter of appreciation
  407. Exploration of the Relationship Between Pain Intensity, Comfort Level and Patient Satisfaction Among Orthopedic Patients Following Knee Surgery on Postoperative …
  408. Graduate Research Symposium
  409. Design and synthesis of novel alpha1 adrenoceptor modulators
  410. Traditional Chinese medicine use amongst women with arthritis: a health services research study
  411. Combined therapies for lysosomal storage diseases
  412. BJMP September 2009 Volume 2 Number 3
  413. From Molecular Understanding to Structure–Thermodynamic Relationships, the Case of Acetylcholine Binding Proteins
  414. Care giving for Alzheimer’s disease: A compassionate guide for clinicians and loved ones
  415. Medicinal Chemistry
  416. Neurochemistry of Endogenous Antinociception
  417. CONTAINING GELLING AGENT 3,276,586 A 10/1966 Rosaen
  418. Japanese use of Beni-tengu-dake (Amanita muscaria) and the efficacy of traditional detoxification methods
  419. Josef Bossart, PhD
  420. Do patients suffer more pain when trainees changeover?
  421. BJMP Sept 2009 Volume 2 Number 3
  422. Design and Synthesis of Novel Linear and Cyclic Peptide Ligands for Kappa Opioid Receptors
  423. FORMULATION OF NANOFIBERS WITH INCORPORATED GROWTH FACTORS AND THEIR EFFECT ON CELL RESPONSE IN VITRO
  424. Expression of functional GABAc receptors in the brain
  425. Synthesis and Screening of Diverse and Three-Dimensional Libraries for Fragment-Based Drug Discovery
  426. Deep phenotypic profiling of neuroactive drugs in larval zebrafish
  427. Efficacy and safety of analgesic treatment for depression in nursing home patients with dementia
  428. Optimization of organotypic hippocampal slice cultures for adult neurogenesis research: exploring pharmacological interactions in newborn dentate granule …
  429. Total Syntheses of Allelopathic 4-Oxyprotoilludanes, Melleolides, and Echinocidins
  430. Total Synthesis of Prostratin, a Bioactive Tigliane Diterpenoid: Access to Multi-Stereocenter Cyclohexanes from a Phenol
  431. Regulation of α7 neuronal nicotinic acetylcholine receptors by extracellular divalent cations
  432. Tandem mass spectrometry of organic nitro and halogen compounds: Competition between losses of molecules and of radicals
  433. CE for Nursing Professionals
  434. Isolation, structure elucidation, and total synthesis of bioactive natural products
  435. Roles of inositol diphosphates in DNA repair and effects of aspirin analogues on oesophageal cancer
  436. Diabetic Foot Ulcer-Treatment
  437. Arthritis and osteoporosis in Australia 2008
  438. Adaptive responses of central cholinergic systems in transgenic mice
  439. 20th International Congress of the European Association for Endoscopic Surgery (EAES) Brussels, Belgium, 20–23 June 2012
  440. Activation of Membrane Progesterone Receptors Mediates the Metabotropic Effects of Neurosteroids on GABAAR Phosphorylation and Tonic Inhibition
  441. Nicotine Addiction: Behavioural and Neurochemical Mechanisms

 

Related Posts

Shopping Cart
Scroll to Top